SITAGLIPTIN/METFORMIN HYDROCHLORIDE TEVA õhukese polümeerikattega tablett एस्टोनिया - एस्टोनियाई - Ravimiamet

sitagliptin/metformin hydrochloride teva õhukese polümeerikattega tablett

teva gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 14tk; 1000mg+50mg 98tk; 1000mg+50mg 28tk; 1000mg+50mg 60tk; 1000mg+50mg 112tk

SITAGLIPTIN/METFORMIN HYDROCHLORIDE TEVA õhukese polümeerikattega tablett एस्टोनिया - एस्टोनियाई - Ravimiamet

sitagliptin/metformin hydrochloride teva õhukese polümeerikattega tablett

teva gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 28tk; 850mg+50mg 60tk; 850mg+50mg 196tk; 850mg+50mg 14tk; 850mg+50mg 112tk; 850mg+50mg 56tk; 850mg+50mg 98tk

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Cuprior यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

cuprior

gmp-orphan sa - trientine tetrahydrochloride - hepatolentikulaarne degeneratsioon - muud alimentary seedetrakti ja ainevahetust tooted, - cuprior on näidustatud ravi wilsoni tõbi täiskasvanutel, noorukitel ja lastel ≥ 5 aastat talu, d-penitsillamiin ravi.

Cardalis यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

cardalis

ceva santé animale - benazepril hydrochloride, spironolactone - sÜdame-veresoonkonna sÜsteem - koerad - ravi südamepuudulikkuse põhjustatud kroonilised degeneratiivsed valvulaarne haigus koertel (diureetikum toetusest, kui see on asjakohane).

Segluromet यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

LIDOCAINE HYDROCHLORIDE INJECTION 1% süstelahus एस्टोनिया - एस्टोनियाई - Ravimiamet

lidocaine hydrochloride injection 1% süstelahus

mefar ilac sanayii a.s. - lidokaiin - süstelahus - 10mg 1ml 5ml 10tk; 10mg 1ml 20ml 10tk